69 related articles for article (PubMed ID: 7431726)
41. [Enzymatic conversion of laminaranes into 1-->3;1-->6-beta-D-glucans, possessing immunostimulating activity].
Zviagintseva TN; Eliakova LA; Isakov VV
Bioorg Khim; 1995 Mar; 21(3):218-25. PubMed ID: 7763320
[TBL] [Abstract][Full Text] [Related]
42. Slight respiratory irritation but not inflammation in mice exposed to (1-->3)-beta-D-glucan aerosols.
Korpi A; Kasanen JP; Kosma VM; Rylander R; Pasanen AL
Mediators Inflamm; 2003 Jun; 12(3):139-46. PubMed ID: 12857597
[TBL] [Abstract][Full Text] [Related]
43. [Immunostimulation in chronic lymphocytic leukemia (author's transl)].
Konopka L; Zywicka-Lopaciuk H; Sylwestrowicz T; Karpowicz M; Cieśluk S; Maślanka K; Pawelski S
Przegl Lek; 1981; 38(5):437-41. PubMed ID: 7268042
[No Abstract] [Full Text] [Related]
44. [Symposium: prevention and treatment of pulmonary tuberculosis in youth (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):117-20. PubMed ID: 7418552
[No Abstract] [Full Text] [Related]
45. [Some problems concerning the epidemiology and control of tuberculosis (author's transl)].
Qiu ZY
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):3-5. PubMed ID: 7428573
[No Abstract] [Full Text] [Related]
46. [A review on tuberculosis control programme in Kanto Region based on the results of sampling survey of tuberculosis registry in 1978 (author's transl)].
Shimao T
Kekkaku; 1980 May; 55(5):225-9. PubMed ID: 7412073
[No Abstract] [Full Text] [Related]
47. [Critique on the prevention and treatment of tuberculosis (author's transl)].
Wu SQ
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):1-2. PubMed ID: 7428569
[No Abstract] [Full Text] [Related]
48. [Clinical and pathological problems in pulmonary tuberculosis (author's transl)].
Iwai K
Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Oct; 19(10):699-706. PubMed ID: 7328945
[No Abstract] [Full Text] [Related]
49. [At the beginning of the last third in the fight against tuberculosis in Switzerland (author's transl)].
Haefliger E
Schweiz Rundsch Med Prax; 1981 Jan; 70(3):57-9. PubMed ID: 7053135
[No Abstract] [Full Text] [Related]
50. [Risk of relapse in tuberculosis].
Forschbach G
Prax Klin Pneumol; 1985 Nov; 39(11):444-6. PubMed ID: 4080667
[No Abstract] [Full Text] [Related]
51. [Observation of tubular myelin figures in experimentally produced tuberculous lesions of mice (author's transl)].
Kanai K; Kondo E; Yasuda T
Kekkaku; 1980 Jun; 55(6):269-71. PubMed ID: 7412078
[No Abstract] [Full Text] [Related]
52. Effectiveness of glucan in the treatment of human neoplasia.
Proctor JW; Yamamura Y
J Natl Cancer Inst; 1978 Nov; 61(5):1179-80. PubMed ID: 280704
[No Abstract] [Full Text] [Related]
53. Anthrax-protective effects of yeast beta 1,3 glucans.
Kournikakis B; Mandeville R; Brousseau P; Ostroff G
MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
[TBL] [Abstract][Full Text] [Related]
54. [Beta-1,3-glucan and other immunomodulators in experimental leprosy infection in mice].
Delville J; Jacques PJ
Acta Leprol; 1979; (76-77):273-81. PubMed ID: 121844
[No Abstract] [Full Text] [Related]
55. Complement function in mAb-mediated cancer immunotherapy.
Gelderman KA; Tomlinson S; Ross GD; Gorter A
Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
[No Abstract] [Full Text] [Related]
56. The role of glucan in the prevention and modification of microparasitic diseases.
Di Luzio NR; Williams DL
Prog Clin Biol Res; 1984; 161():443-56. PubMed ID: 6435131
[No Abstract] [Full Text] [Related]
57. [Experimental studies on the use of an immunoadjuvant (beta-1, 3 glucan) to prevent relapse after termination of chemotherapy in mouse model (author's transl)].
Kondo E; Kanai K
Kekkaku; 1980 Sep; 55(9):411-4. PubMed ID: 7431726
[No Abstract] [Full Text] [Related]
58. [beta-1, 3 glucan as an immunopotentiator against experimental tuberculous infection in mice (author's transl)].
Kanai K; Kondo E
Kekkaku; 1980 Aug; 55(8):371-4. PubMed ID: 7420811
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
